Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$94.6M |
| 2 |
JD.com
JD
|
+$52.3M |
| 3 |
CRISPR Therapeutics
CRSP
|
+$51.7M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$48.3M |
| 5 |
Baidu
BIDU
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$82.2M |
| 2 |
Apple
AAPL
|
+$32.4M |
| 3 |
RDFN
Redfin
RDFN
|
+$27.3M |
| 4 |
XYZ
Block Inc
XYZ
|
+$25.8M |
| 5 |
Amazon
AMZN
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.78% |
| 2 | Technology | 26.07% |
| 3 | Communication Services | 15.57% |
| 4 | Consumer Discretionary | 14.57% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ametek
AME
$54.9B
| $662K | 0.02% |
8,369
+1,687
| +25% | +$129K |
|
|
CEL
102
DELISTED
Cellcom Israel, Ltd.
CEL
| $654K | 0.02% |
94,696
+23,319
| +33% | +$138K |
|
103
Medtronic
MDT
$119B
| $648K | 0.02% |
+6,588
| New | +$609K |
|
104
Moog Inc Class A
MOG.A
$12.3B
| $627K | 0.02% |
7,298
+370
| +5% | +$29.2K |
|
105
Ituran Location and Control
ITRN
$1.01B
| $624K | 0.02% |
18,127
+1,446
| +9% | +$47.8K |
|
|
CYBR
106
DELISTED
CyberArk
CYBR
| $623K | 0.02% |
7,800
-2,542
| -25% | -$179K |
|
107
Indaptus Therapeutics
INDP
$172M
| $609K | 0.02% |
+48
| New | +$456K |
|
108
Kamada
KMDA
$475M
| $606K | 0.02% |
97,391
-22,146
| -19% | -$127K |
|
109
United Parcel Service
UPS
$86.8B
| $603K | 0.02% |
5,164
-271
| -5% | -$31.9K |
|
110
Stryker
SYK
$126B
| $599K | 0.02% |
3,370
-293
| -8% | -$50K |
|
111
WIX.com
WIX
$3.43B
| $598K | 0.02% |
4,992
-1,081
| -18% | -$116K |
|
|
PNTR
112
DELISTED
Pointer Telocation Ltd.
PNTR
| $595K | 0.02% |
45,757
+9,963
| +28% | +$122K |
|
113
Camtek
CAMT
$6.85B
| $583K | 0.02% |
68,052
-7,392
| -10% | -$64.9K |
|
114
Silicom
SILC
$253M
| $580K | 0.02% |
14,299
-630
| -4% | -$24.3K |
|
115
Check Point Software Technologies
CHKP
$13.3B
| $577K | 0.02% |
4,901
-367
| -7% | -$41.7K |
|
|
FOMX
116
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $572K | 0.02% |
99,901
-6,342
| -6% | -$36.3K |
|
117
Nice
NICE
$5.87B
| $565K | 0.02% |
4,934
-712
| -13% | -$79.6K |
|
118
Gilat Satellite Networks
GILT
$809M
| $539K | 0.02% |
61,247
-3,533
| -5% | -$31.4K |
|
|
CALL
119
DELISTED
magicJack VocalTec Ltd
CALL
| $537K | 0.02% |
64,357
-987
| -2% | -$8.4K |
|
120
UroGen Pharma
URGN
$2.29B
| $532K | 0.02% |
11,258
+1,820
| +19% | +$84.6K |
|
121
Tower Semiconductor
TSEM
$25.2B
| $524K | 0.02% |
24,089
+5,597
| +30% | +$120K |
|
122
Radware
RDWR
$1.17B
| $522K | 0.02% |
19,730
-4,791
| -20% | -$128K |
|
|
ORBK
123
DELISTED
Orbotech Ltd
ORBK
| $512K | 0.02% |
8,620
-485
| -5% | -$30.3K |
|
|
NVMI
124
Nova
NVMI
$12B
| $497K | 0.02% |
18,879
-412
| -2% | -$11.4K |
|
125
Teva Pharmaceuticals
TEVA
$43.5B
| $497K | 0.02% |
23,063
-7,424
| -24% | -$172K |
|
Similar funds
Cathie Wood's Q3 2018 Portfolio in Review
As of Q3 2018, Cathie Wood held 218 positions worth $3.31B, up 21% from $2.73B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Cathie Wood deployed $446M of net new capital in Q3 2018, opening 18 new positions and adding to 100 existing holdings. Its largest new stake was Advanced Micro Devices: 640,180 shares worth $19.8M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Athenahealth, Inc., an estimated $82.2M trimmed.
- Cathie Wood's largest Q3 2018 buy was Advanced Micro Devices: 640,180 shares worth $19.8M.
- Cathie Wood added most to Tesla in Q3 2018, an estimated $94.6M increase.
- Cathie Wood's biggest Q3 2018 reduction was Athenahealth, Inc., cutting an estimated $82.2M.
- Cathie Wood fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $12.8M.
- Cathie Wood's ten largest holdings make up 40% of its $3.31B portfolio in Q3 2018.
- Cathie Wood opened 18 new positions and closed 16 in Q3 2018.
- Cathie Wood's portfolio value rose 21% quarter-over-quarter to $3.31B.
Based on ARK Investment Management's 13F filing for Q3 2018, filed 7 Nov 2018.